AARP's new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...

People with Medicare Part D plans shoulder a share of the cost of their prescription drugs. Under the standard Part D benefit ...

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

Drugmakers have greeted 2025, implementing price hikes for 583 products within the first two days of the new year, according ...

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

Beyond the influence of new therapies on drug pricing trends, Cowen’s report also accounted for the effects of legislation ...

Top Medicare Part D drugs without price negotiations have seen a 98% increase in list prices since their launch. Read more ...

Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet ...

Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...

Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.

The Biden administration’s justification of the first cycle of Medicare drug price negotiations is fueling curiosity and ...

International price referencing for certain drugs could be revisited during the second Trump administration. But it's ...